Switching from deuruxolitinib to baricitinib in alopecia areata
A real-world cohort of 36 patients.
Hermosa-Gelbard A, Buendia-Castaño D, Jimenez-Cauhe J, Velasco-Tamariz V, Morales-Munera CE, Lobato-Berezo A, Lecumberri A, Vaño-Galvan S, Saceda-Corralo D
Journal of the American Academy of DermatologyIn the feed 6 Aug 2026, published online 6 Aug 2026, issue 2026 Aug 06, added to PubMed 6 Aug 2026
Topics: HairJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42562095 · DOI 10.1016/j.jaad.2026.08.001